News|Articles|February 23, 2026
Conference Preview: Late-Breaking Abstracts at ASCO GU 2026
Author(s)Hannah Clarke
Fact checked by: Benjamin P. Saylor, Strategic Content Lead
Take a look into the top data set to be presented at this year's ASCO GU Cancers Symposium in San Francisco, California.
Advertisement
Advertisement
The late-breaking abstracts (LBAs) at this year’s American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium offer an early look at data that may meaningfully shift clinical decision-making across urologic oncology. As the treatment landscape continues to evolve, particularly with the expansion of targeted therapies, antibody-drug conjugates, and perioperative immunotherapy strategies, this year’s LBA slate reflects a growing emphasis on biomarker-driven care and treatment intensification across disease states.
Advertisement
Advertisement